Register entry

RVL Pharmaceuticals, Inc.

Data as of · How to read this entry

Registered sites
0
Active NDC listings
1
Live patents
14
Countries
0
Exclusivity

Patents and exclusivities

14
PatentProductCoversExpiry
10912765UPNEEQoxymetazoline hydrochlorideuseAug 2031
8357714UPNEEQoxymetazoline hydrochlorideuseAug 2031
9867808UPNEEQoxymetazoline hydrochlorideuseAug 2031
10799481UPNEEQoxymetazoline hydrochlorideuseDec 2039
10814001UPNEEQoxymetazoline hydrochlorideproductDec 2039
10898573UPNEEQoxymetazoline hydrochlorideproductDec 2039
10940138UPNEEQoxymetazoline hydrochlorideuseDec 2039
11103482UPNEEQoxymetazoline hydrochlorideproductDec 2039
11311515UPNEEQoxymetazoline hydrochlorideproductDec 2039
11324722UPNEEQoxymetazoline hydrochlorideuseDec 2039
11541036UPNEEQoxymetazoline hydrochlorideproductDec 2039
11701343UPNEEQoxymetazoline hydrochlorideuseDec 2039
12605363UPNEEQoxymetazoline hydrochlorideproductDec 2039
12648930UPNEEQoxymetazoline hydrochlorideuseDec 2039
Catalogue

Marketed products

1
BrandGeneric nameForm / routeNDC
UPNEEQOxymetazoline hydrochloride ophthalmicsolution/ drops, ophthalmic73687-062NDA
Enquiry

Common questions

Is RVL Pharmaceuticals, Inc. FDA approved?
RVL Pharmaceuticals, Inc. holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does RVL Pharmaceuticals, Inc. make?
1 product is listed under RVL Pharmaceuticals, Inc. in the openFDA NDC Directory, most often as solution/ drops. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.